Be cautious if the prices seem far below market value
Potential Side Effects and Prevalence Like any medication, there is an inherent risk of adverse effects, and unfortunately, with this class of medications, they are quite common
Strategies to optimize the therapeutic potential of LC while minimizing its cardiovascular risks are imperative to guide clinical practice and public health recommendations
Champe PC, Harvey RA, Ferrier DR (2008)
The TRIUMPH clinical trial program is evaluating retatrutide for multiple indications beyond simple weight loss, including obesity with osteoarthritis, obesity with metabolic complications, type 2 diabetes, cardiovascular outcomes, obstructive sleep apnea, and metabolic dysfunction-associated steatohepatitis
About 1 in 8 Americans uses GLP-1 drugs for diabetes, weight loss and other chronic conditions, including semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)